食品伙伴网讯 据欧盟食品安全局（EFSA）消息，11月21日欧盟食品安全局就埃玛菌素（emamectin）的农药风险评估同行评审发布了结论。
欧盟食品安全局认为，当埃玛菌素用于葡萄时，会对水生生物构成较大的风险；埃玛菌素还会对蜜蜂、arthropos等非靶标生物构成较大的风险。
部分原文报道如下：
Emamectin is a new active substance for which in accordance with Article 6（2） of Council Directive 91/414/EEC the Netherlands （hereinafter referred to as the 'RMS'） received an application from Syngenta Crop Protection AG for approval. Complying with Article 6（3） of Directive 91/414/EEC, the completeness of the dossier was checked by the RMS. The European Commission recognised in principle the completeness of the dossier by Commission Decision 2007/669/EC.
The RMS provided its initial evaluation of the dossier on emamectin in the Draft Assessment Report （DAR）， which was received by the EFSA on 6 March 2008. The peer review was initiated on 5 October 2011 by dispatching the DAR for consultation of the Member States and the applicant Syngenta Crop Protection AG.
Following consideration of the comments received on the DAR, it was concluded that EFSA should conduct an expert consultation in the areas of mammalian toxicology, residues, fate and behaviour and ecotoxicology and EFSA should adopt a conclusion on whether emamectin can be expected to meet the conditions provided for in Article 5 of Directive 91/414/EEC, in accordance with Article 8 of Commission Regulation （EU） No 188/2011.
原文链接：<http://www.efsa.europa.eu/en/efsajournal/pub/2955.htm>
